RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Rekah Pharmaceutical Industry Stock

Rekah Pharmaceutical Industry Debt 2025

Rekah Pharmaceutical Industry Debt

127.13 ILS

Ticker

REKA.TA

ISIN

IL0010810096

In 2025, Rekah Pharmaceutical Industry's total debt was 127.13 ILS, a -22.65% change from the 164.35 ILS total debt recorded in the previous year.

Rekah Pharmaceutical Industry Aktienanalyse

What does Rekah Pharmaceutical Industry do?

Rekah Pharmaceutical Industry ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Rekah Pharmaceutical Industry's Debt Structure

Rekah Pharmaceutical Industry's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Rekah Pharmaceutical Industry's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Rekah Pharmaceutical Industry’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Rekah Pharmaceutical Industry’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Rekah Pharmaceutical Industry stock

What is the debt of Rekah Pharmaceutical Industry this year?

Rekah Pharmaceutical Industry has a debt level of 127.13 ILS this year.

What was the debt of Rekah Pharmaceutical Industry compared to the previous year?

The debt of Rekah Pharmaceutical Industry has increased by -22.65% compared to the previous year dropped.

What are the consequences of high debt for investors in Rekah Pharmaceutical Industry?

High debt can pose a risk for investors of Rekah Pharmaceutical Industry, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Rekah Pharmaceutical Industry?

Low debt means that Rekah Pharmaceutical Industry has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Rekah Pharmaceutical Industry affect the company?

An increase in debt of Rekah Pharmaceutical Industry can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Rekah Pharmaceutical Industry affect the company?

A reduction in debt of Rekah Pharmaceutical Industry can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Rekah Pharmaceutical Industry?

Some factors that can influence the debt of Rekah Pharmaceutical Industry include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Rekah Pharmaceutical Industry so important for investors?

The debts of Rekah Pharmaceutical Industry are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Rekah Pharmaceutical Industry take to change the debt?

To change the debt, Rekah Pharmaceutical Industry can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Rekah Pharmaceutical Industry pay?

Over the past 12 months, Rekah Pharmaceutical Industry paid a dividend of 0.87 ILS . This corresponds to a dividend yield of about 0.07 %. For the coming 12 months, Rekah Pharmaceutical Industry is expected to pay a dividend of 0 ILS.

What is the dividend yield of Rekah Pharmaceutical Industry?

The current dividend yield of Rekah Pharmaceutical Industry is 0.07 %.

When does Rekah Pharmaceutical Industry pay dividends?

Rekah Pharmaceutical Industry pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Rekah Pharmaceutical Industry?

Rekah Pharmaceutical Industry paid dividends every year for the past 0 years.

What is the dividend of Rekah Pharmaceutical Industry?

For the upcoming 12 months, dividends amounting to 0 ILS are expected. This corresponds to a dividend yield of 0 %.

In which sector is Rekah Pharmaceutical Industry located?

Rekah Pharmaceutical Industry is assigned to the 'Health' sector.

Wann musste ich die Aktien von Rekah Pharmaceutical Industry kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Rekah Pharmaceutical Industry from 4/14/2022 amounting to 0.868 ILS, you needed to have the stock in your portfolio before the ex-date on 4/6/2022.

When did Rekah Pharmaceutical Industry pay the last dividend?

The last dividend was paid out on 4/14/2022.

What was the dividend of Rekah Pharmaceutical Industry in the year 2024?

In the year 2024, Rekah Pharmaceutical Industry distributed 0.868 ILS as dividends.

In which currency does Rekah Pharmaceutical Industry pay out the dividend?

The dividends of Rekah Pharmaceutical Industry are distributed in ILS.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Rekah Pharmaceutical Industry

Our stock analysis for Rekah Pharmaceutical Industry Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rekah Pharmaceutical Industry Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.